Twist Bioscience Corp


Market Cap$2.4B

Compare Twist Bioscience

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Twist Bioscience CorpTwist Bioscience Corp-11.70%-35%9.7-
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

27.3% upside

Undervalued by 27.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.40 Billion
Enterprise Value$2.09 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-3.6
Outstanding Shares57,818,022
Avg 30 Day Volume1,140,420


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.66
Price to Sales9.66
Price to Book Ratio3.86
Enterprise Value to Revenue7.96
Enterprise Value to EBIT-10.18
Enterprise Value to Net Income-11
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Twist Bioscience Corp

CEO: Emily Leproust

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...